Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oral liquid for treating child mycoplasma pneumonia

A technology of mycoplasma pneumonia and oral liquid, which is applied in the direction of medical raw materials derived from mammals, unknown raw materials, plant raw materials, etc., can solve the problems of strong side effects of the digestive system, unsuitable for radical cure, and easy recurrence, etc., achieving significant curative effect, no toxic side effects, quick results

Inactive Publication Date: 2014-05-07
SHANDONG UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The clinical symptoms of mycoplasma pneumonia caused by Mycoplasma pneumoniae are frequent and severe intractable cough. The course of the disease is 1 to 2 months. Drugs of the erythromycin group are mainly used in the treatment of this disease, the course of treatment is long, and the side effects of the digestive system are strong.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Embodiment 1 prepares the oral liquid for the treatment of infantile mycoplasma pneumonia

[0013] The formula is: 45 grams of roasted ephedra, 35 grams of fried perilla, 15 grams of mulberry white skin, 15 grams of Houttuynia cordata, 25 grams of Uncaria, 45 grams of bezoar, 15 grams of musk, 45 grams of Bupleurum, 25 grams of tangerine peel, Magnolia officinalis 25 grams.

[0014] The preparation method is as follows: take the raw materials, mix them, add water to decoct for 1.5 hours, filter to obtain the filtrate, add water to the filter residue and decoct for 1.5 hours, filter to obtain the filtrate, combine the two filtrates, concentrate to a relative density of 1.22-1.24 (50°C ), that is.

Embodiment 2

[0015] Embodiment 2 prepares the oral liquid for the treatment of mycoplasma pneumonia in children

[0016] The formula is: 42 grams of roasted ephedra, 38 grams of fried perilla, 12 grams of mulberry bark, 18 grams of Houttuynia cordata, 22 grams of Uncaria, 48 grams of bezoar, 12 grams of musk, 48 grams of Bupleurum, 22 grams of tangerine peel, Magnolia officinalis 28 grams.

[0017] The preparation method is as follows: take the raw materials, mix them, add water to decoct for 1.5 hours, filter to obtain the filtrate, add water to the filter residue and decoct for 1.5 hours, filter to obtain the filtrate, combine the two filtrates, concentrate to a relative density of 1.22-1.24 (50°C ), that is.

Embodiment 3

[0018] Embodiment 3 prepares the oral liquid for the treatment of infantile mycoplasma pneumonia

[0019] The formula is: 47 grams of roasted ephedra, 33 grams of fried perilla, 17 grams of mulberry bark, 13 grams of Houttuynia cordata, 27 grams of Uncaria, 43 grams of bezoar, 17 grams of musk, 43 grams of Bupleurum, 27 grams of tangerine peel, Magnolia officinalis 23 grams.

[0020] The preparation method is as follows: take the raw materials, mix them, add water to decoct for 2 hours, filter to obtain the filtrate, add water to the filter residue and decoct for 1.5 hours, filter to obtain the filtrate, combine the two filtrates, concentrate to a relative density of 1.22-1.24 (50°C ), that is.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an oral liquid for treating child mycoplasma pneumonia. The oral liquid is prepared from the following bulk pharmaceuticals by weight: 40-50g of roasted Chinese ephedra, 30-40g of fried perilla seed, 10-20g of white mulberry boot-bark, 10-20g of heartleaf houttuynia herb, 20-30g of uncaria, 40-50g of calculus bovis, 10-20g of moschus, 40-50g of Chinese thorowax root, 20-30g of dried orange peel and 20-30g of officinal magnolia bark. During treatment, the oral liquid is taken orally for 3-4 times every day, every time for 5-10ml. The child mycoplasma pneumonia can be cured about half a month generally. The oral liquid for treating child mycoplasma pneumonia disclosed by the invention has a remarkable curative effect and quick response, and is free from toxic and side effects; and the total effective rate is up to 97.8 percent.

Description

technical field [0001] The invention relates to an oral liquid for treating children with mycoplasma pneumonia. Background technique [0002] Mycoplasma pneumonia in children is a mycoplasma pneumonia caused by Mycoplasma pneumoniae. It is a common and frequently-occurring disease in pediatrics. Whenever spring and autumn alternate seasons, children often suffer from this disease due to their low immunity. The clinical symptoms of mycoplasma pneumonia caused by Mycoplasma pneumoniae are frequent and severe intractable cough. The course of the disease is 1 to 2 months. Drugs of the erythromycin group are mainly used in the treatment of this disease, and the course of treatment is long and the side effects of the digestive system are strong. It is not suitable for a radical cure and is prone to recurrence. At present, there is an urgent need to research and develop new products with significant curative effect and few side effects on the market. Contents of the invention ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/78A61K9/08A61P11/00A61P31/00A61K35/55A61K35/413
Inventor 孟晓慧李茜董波
Owner SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com